Role of Galectin-3 in Acetaminophen-Induced Hepatotoxicity and Inflammatory Mediator Production
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Galectin-3 in Acetaminophen-Induced Hepatotoxicity and Inflammatory Mediator Production
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 127, Issue 2, Pages 609-619
Publisher
Oxford University Press (OUP)
Online
2012-03-30
DOI
10.1093/toxsci/kfs117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Macrophages and Tissue Injury: Agents of Defense or Destruction?
- (2011) Debra L. Laskin et al. Annual Review of Pharmacology and Toxicology
- CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice
- (2011) Hang Thi Thu Nguyen et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation
- (2011) Erawan Borkham-Kamphorst et al. LIVER INTERNATIONAL
- Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1
- (2011) Ana-Cristina Dragomir et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis
- (2010) Huamei Forsman et al. ARTHRITIS AND RHEUMATISM
- Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
- (2010) Carla Iacobini et al. JOURNAL OF HEPATOLOGY
- Galectin-3 Exerts Cytokine-Like Regulatory Actions through the JAK-STAT Pathway
- (2010) S.-B. Jeon et al. JOURNAL OF IMMUNOLOGY
- Galectin-3 contributes to neonatal hypoxic–ischemic brain injury
- (2010) Christina Doverhag et al. NEUROBIOLOGY OF DISEASE
- Old and new generation lipid mediators in acute inflammation and resolution
- (2010) Melanie J. Stables et al. PROGRESS IN LIPID RESEARCH
- Potential role of caveolin-1 in acetaminophen-induced hepatotoxicity
- (2010) Carol R. Gardner et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Role of caspase-1 and interleukin-1β in acetaminophen-induced hepatic inflammation and liver injury
- (2010) C. David Williams et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- CXC chemokines play a critical role in liver injury, recovery, and regeneration
- (2009) Callisia N. Clarke et al. AMERICAN JOURNAL OF SURGERY
- Macrophages and Inflammatory Mediators in Chemical Toxicity: A Battle of Forces
- (2009) Debra L. Laskin CHEMICAL RESEARCH IN TOXICOLOGY
- Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes
- (2009) Markus Weber et al. FEBS LETTERS
- The regulation of inflammation by galectin-3
- (2009) Neil C. Henderson et al. IMMUNOLOGICAL REVIEWS
- Endogenous galectins and the control of the host inflammatory response
- (2009) Lucy V Norling et al. JOURNAL OF ENDOCRINOLOGY
- The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice
- (2009) Brittany V. Martin-Murphy et al. TOXICOLOGY LETTERS
- Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
- (2008) E.P.K. Mensah-Brown et al. CLINICAL IMMUNOLOGY
- A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury
- (2008) Ana Paula Fernandes Bertocchi et al. TRANSPLANT INTERNATIONAL
- Galectin-3 Is an Amplifier of Inflammation in Atherosclerotic Plaque Progression Through Macrophage Activation And Monocyte Chemoattraction
- (2007) Marianna Papaspyridonos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More